Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NBTY Expects Potholes On Private Label Profit Road

This article was originally published in The Tan Sheet

Executive Summary

Dietary supplement manufacturer and retailer NBTY expects increased competition in the store brand arena to drive down its gross profits, nearly two years after it made private label sales a much larger part of its business by acquiring competitor Leiner Health Products

You may also be interested in...



Carlyle Group's $3.8B Bid For NBTY Could Face Competition

The Carlyle Group's planned acquisition of NBTY for $3.8 billion may not be the only private equity offer to surface for the dietary supplement giant

Carlyle Group's $3.8B Bid For NBTY Could Face Competition

The Carlyle Group's planned acquisition of NBTY for $3.8 billion may not be the only private equity offer to surface for the dietary supplement giant

Carlyle Group's $3.8B Bid For NBTY Could Face Competition

The Carlyle Group's planned acquisition of NBTY for $3.8 billion may not be the only private equity offer to surface for the dietary supplement giant

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS104071

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel